Please provide your email address to receive an email when new articles are posted on . A non-deceptive placebo injection reduced chronic back pain with effect size similar to typical treatments.

Patients not already receiving buprenorphine can receive the first injection of Sublocade following a single dose of transmucosal buprenorphine and a 1 hour observation period to confirm tolerability.

2 Department of Neurology, Royal Perth Hospital, Perth, Western Australia 3 Department of Radiology, Royal Perth Hospital, Perth, Western Australia Correspondence to Dr Barbara J Singer, School of ...

The notification states that there is no risk to product quality because of the labelling error ...